Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_provenance.
- NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_assertion description "[Our identification of XRCC2 as a breast cancer susceptibility gene thus increases the proportion of breast cancers that are associated with homologous recombination-DNA-repair dysfunction and Fanconi anemia and could therefore benefit from specific targeted treatments such as PARP (poly ADP ribose polymerase) inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_provenance.
- NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_assertion evidence source_evidence_literature NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_provenance.
- NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_assertion SIO_000772 22464251 NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_provenance.
- NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_assertion wasDerivedFrom befree-20140225 NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_provenance.
- NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_assertion wasGeneratedBy ECO_0000203 NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_provenance.
- befree-20140225 importedOn "2014-02-25" NP420197.RAUwdOQvHhl65X7pGPiCu4hyy9uB_QqLa_aQCgI_ule64130_provenance.